Drug application

BETAPAR (MEPREDNISONE)

Drugs@FDA NDA 016053 · SCHERING

Key facts

Drug name BETAPAR
Active ingredients MEPREDNISONE
Application type NDA
Application number 016053
Company SCHERING
Dosage forms TABLET, ORAL
Strength 4MG
Marketing status Discontinued
Reference listed drug No

At a glance

  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications